A SIMPLE AND RAPID FLUOROMETRIC-DETERMINATION METHOD OF ALPHA(1)-ACID GLYCOPROTEIN IN SERUM USING QUINALDINE RED

被引:24
作者
IMAMURA, H
MARUYAMA, T
OKABE, H
SHIMADA, H
OTAGIRI, M
机构
[1] KUMAMOTO UNIV,FAC PHARMACEUT SCI,KUMAMOTO 862,JAPAN
[2] KUMAMOTO UNIV,SCH MED,KUMAMOTO 862,JAPAN
[3] SHIMADA HOSP,KUMAMOTO 860,JAPAN
关键词
ALPHA(1)-ACID GLYCOPROTEIN; FLUORESCENT PROBE; QUINALDINE RED; SINGLE RADIAL IMMUNODIFFUSION METHOD;
D O I
10.1023/A:1018926902083
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
We examined different fluorescent probes suitable for fluorometric determination of alpha(1)-acid glycoprotein (AGP) in serum. Quinaldine red (QR) was shown to bind strongly and selectively to AGP. Taking advantage of the enhanced fluorescence of QR in the presence of AGP, we developed a direct method for the determination of serum AGP without removal of other serum proteins such as albumin. AGP concentrations in serum of healthy volunteers and patients correlated well with results from the conventional single radial immunodiffusion (SRID) method (r = 0.93, slope = 1). The newly developed method is faster and has a larger analytical concentration range than the SRID method. This method can also be used to determine AGP in serum of experimental animals, and it can serve to monitor AGP serum concentrations for pharmacokinetic evaluation of basic drugs.
引用
收藏
页码:566 / 570
页数:5
相关论文
共 14 条
[1]  
BELAPAIRE FM, 1982, EUR J CLIN PHARMACOL, V22, P253
[2]  
CHERESH DA, 1984, IMMUNOLOGY, V51, P541
[3]  
FRED PA, 1982, CLIN PHARMACOL THER, V32, P659
[4]   THE MICROHETEROGENEITY OF ALPHA-1-ACID GLYCOPROTEIN IN INFLAMMATORY LUNG-DISEASE, CANCER OF THE LUNG AND NORMAL HEALTH [J].
HANSEN, JES ;
LARSEN, VA ;
BOGHANSEN, TC .
CLINICA CHIMICA ACTA, 1984, 138 (01) :41-47
[5]  
IMAMURA H, 1993, BIOL PHARM BULL, V16, P926
[6]  
JULIUS KJ, 1968, BIOCHIM BIOPHYS ACTA, V170, P324
[7]   EFFECTS OF INFLAMMATORY DISEASE ON PLASMA OXPRENOLOL CONCENTRATIONS [J].
KENDALL, MJ ;
QUARTERMAN, CP ;
BISHOP, H ;
SCHNEIDER, RE .
BRITISH MEDICAL JOURNAL, 1979, 2 (6188) :465-468
[8]  
KREMER JMH, 1988, PHARMACOL REV, V40, P1
[9]  
PARVAIZ S, 1988, FASEB J, V1, P209
[10]   LIDOCAINE PLASMA-PROTEIN BINDING [J].
ROUTLEDGE, PA ;
BARCHOWSKY, A ;
BJORNSSON, TD ;
KITCHELL, BB ;
SHAND, DG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (03) :347-351